Venturi Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$441K Buy
7,650
+1,578
+26% +$90.6K 0.02% 411
2026
Q1
$368K Buy
6,072
+697
+13% +$40.6K 0.02% 420
2025
Q4
$290K Sell
5,375
-583
-10% -$28K 0.01% 466
2025
Q3
$269K Buy
5,958
+451
+8% +$21.1K 0.01% 465
2025
Q2
$255K Sell
5,507
-1,121
-17% -$55K 0.01% 465
2025
Q1
$404K Buy
6,628
+603
+10% +$35.1K 0.02% 366
2024
Q4
$341K Buy
6,025
+3,127
+108% +$175K 0.02% 414
2024
Q3
$150K Buy
2,898
+1,558
+116% +$73.1K 0.01% 480
2024
Q2
$55.7K Buy
1,340
+129
+11% +$5.77K ﹤0.01% 638
2024
Q1
$65.7K Buy
1,211
+335
+38% +$17.1K ﹤0.01% 468
2023
Q4
$44.9K Buy
876
+134
+18% +$7.03K ﹤0.01% 506
2023
Q3
$43.1K Sell
742
-7
-0.9% -$429 ﹤0.01% 495
2023
Q2
$47.9K Sell
749
-16
-2% -$1.07K ﹤0.01% 430
2023
Q1
$53K Buy
+765
New +$54K ﹤0.01% 461
2020
Q3
Sell
-8,675
Closed -$510K 284
2020
Q2
$510K Buy
8,675
+2,280
+36% +$136K 0.07% 186
2020
Q1
$356K Buy
+6,395
New +$391K 0.06% 154

Other funds holding BMY

Venturi Wealth Management's BMY Position: Q2 2026 in Review

Venturi Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, buying an estimated $90.6K and bringing the position to 7,650 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #411.

Venturi Wealth Management first reported a position in BMY in Q1 2020 and has held it in 16 quarters since. The position peaked at $510K in Q2 2020. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Venturi Wealth Management held 7,650 shares of Bristol-Myers Squibb worth $441K as of Q2 2026.
  • Venturi Wealth Management bought 1,578 Bristol-Myers Squibb shares in Q2 2026, an estimated $90.6K.
  • Bristol-Myers Squibb made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #411 holding.
  • Venturi Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 16 quarters since.
  • Venturi Wealth Management's Bristol-Myers Squibb position peaked at $510K in Q2 2020.
  • 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.